The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
PBPK modeling and simulation in drug research and development
Open accessAbstract
Physiologically based pharmacokinetic (PBPK) modeling and simulation can be used to predict the pharmacokinetic behavior of drugs in humans using preclinical data. It can also explore the effects of various physiologic parameters such as age, ethnicity, or disease status on human pharmacokinetics, as well as guide dose and dose regiment selection and aid drug-drug interaction risk assessment. PBPK modeling has developed rapidly in the last decade within both the field of academia and the pharmaceutical industry, and has become an integral tool in drug discovery and development. In this mini-review, the concept and methodology of PBPK modeling are briefly introduced. Several case studies were discussed on how PBPK modeling and simulation can be utilized through various stages of drug discovery and development. These case studies are from our own work and the literature for better understanding of the absorption, distribution, metabolism and excretion (ADME) of a drug candidate, and the applications to increase efficiency, reduce the need for animal studies, and perhaps to replace clinical trials. The regulatory acceptance and industrial practices around PBPK modeling and simulation is also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiological Parameter Values for Physiologically Based Pharmacokinetic Models
Brown, R. P., Delp, M. D., Lindstedt, S. L., Rhomberg, L. R., & Beliles, R. P. (1997) · Toxicology and Industrial Health · doi:10.1177/074823379701300401 · Cited by 1,415
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Jones, H., Chen, Y., Gibson, C., Heimbach, T., Parrott, N., Peters, S., Snoeys, J., Upreti, V., Zheng, M., & Hall, S. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.37 · Cited by 488
A Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics
Jones, H. M., Parrott, N., Jorga, K., & Lav??, T. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645050-00006 · Cited by 352
Wagner, C., Zhao, P., Pan, Y., Hsu, V, Grillo, J., Huang, S., & Sinha, V (2015) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.33 · Cited by 276
Teorell, T. (1937) · Archives internationales de pharmacodynamie et de thérapie · Cited by 260
Chu, X., Korzekwa, K., Elsby, R., Fenner, K., Galetin, A., Lai, Y., Matsson, P., Moss, A., Nagar, S., Rosania, G. R., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.78 · Cited by 236
Zhao, P., Rowland, M., & Huang, S.-M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.68 · Cited by 212
Regulatory Experience With Physiologically Based Pharmacokinetic Modeling for Pediatric Drug Trials
Leong, R., Vieira, M. L. T., Zhao, P., Mulugeta, Y., Lee, C. S., Huang, S.-M., & Burckart, G. J. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.19 · Cited by 187
Physiologically Based Pharmacokinetic Modeling: Science and Applications
(2005) · Wiley eBooks · doi:10.1002/0471478768 · Cited by 175
Wagner, C., Pan, Y., Hsu, V., Grillo, J. A., Zhang, L., Reynolds, K. S., Sinha, V., & Zhao, P. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0188-4 · Cited by 148
Lu, C., Li, P., Gallegos, R., Uttamsingh, V., Xia, C. Q., Miwa, G. T., Balani, S. K., & Gan, L.-S. L. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.010793 · Cited by 147
Self-citationManolis, E., & Pons, G. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03484.x · Cited by 124
Parrott, N. J., Davies, B., Hoffmann, G., Koerner, A., Lavé, T., Prinssen, E. P. M., Theogaraj, E., & Singer, T. (2011) · Clinical Pharmacokinetics · doi:10.2165/11592640-000000000-00000 · Cited by 116
Peters, S. A., Jones, C. R., Ungell, A.-L. B., & Hatley, O. J. D. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0351-6 · Cited by 110
Zhao, P., Vieira, M. D. L. T., Grillo, J. A., Song, P., Wu, T., Zheng, J., Arya, V., Berglund, E. G., Atkinson, A. J., Sugiyama, Y., et al. (2012) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011415528 · Cited by 98
Wagner, C., Pan, Y., Hsu, V., Sinha, V. P., & Zhao, P. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0330-y · Cited by 93
Application of PBPK modelling in drug discovery and development at Pfizer
Jones, H. M., Dickins, M., Youdim, K., Gosset, J. R., Attkins, N. J., Hay, T. L., Gurrell, I. K., Logan, Y. R., Bungay, P. J., Jones, B. C., et al. (2012) · Xenobiotica · doi:10.3109/00498254.2011.627477 · Cited by 92
Zhao, P., Ragueneau, I., Zhang, L., Strong, J. M., Reynolds, K. S., Levy, R. H., Thummel, K. E., & Huang, S. M. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008331196 · Cited by 84
Vieira, M. D. L. T., Kim, M.-J., Apparaju, S., Sinha, V. P., Zineh, I., Sm, H., & Zhao, P. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.43 · Cited by 66
Plowchalk, D. R., & Yeo, K. R. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1189-y · Cited by 62
Physiologically Based Pharmacokinetic Modeling: From Regulatory Science to Regulatory Policy
Sinha, V. P., Zhao, P., Huang, S. M., & Zineh, I. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.46 · Cited by 58
Physiologically Based Pharmacokinetic Modeling???Science and Applications
Molnar, J. (2006) · American Journal of Therapeutics · doi:10.1097/00045391-200603000-00018 · Cited by 47
Zhuang, X., Zhong, Y.-H., Xiao, W., Li, H., & Lu, C. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.053199 · Cited by 43
Self-citationImpact of Physiologically Based Pharmacokinetic Modeling and Simulation in Drug Development
Shardlow, C. E., Generaux, G. T., Patel, A. H., Tai, G., Tran, T. B., & Bloomer, J. C. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052803 · Cited by 42
Suri, A., Chapel, S. H., Lu, C., & Venkatakrishnan, K. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.155 · Cited by 32
Self-citationPBPK as a tool in regulatory review
Huang, S. M. (2012) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1777 · Cited by 30
Liu, F., Zhuang, X., Yang, C., Li, Z., Xiong, S., Zhang, Z., Li, J., Lu, C., & Zhang, Z. (2014) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1897 · Cited by 25
Self-citationPeters, S. A., Ungell, A.-L. B., & Dolgos, H. (2009) · PubMed · Cited by 25
Cited by
Why 90% of clinical drug development fails and how to improve it?
Sun, D., Gao, W., Hu, H., & Zhou, S. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.002 · Cited by 1,763
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
Vora, L. K., Gholap, A. D., Jetha, K., Thakur, R. R. S., Solanki, H. K., & Chavda, V. P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071916 · Cited by 1,061
Computational Approaches in Preclinical Studies on Drug Discovery and Development
Wu, F., Zhou, Y., Li, L., Shen, X., Chen, G., Wang, X., Liang, X., Tan, M., & Huang, Z. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00726 · Cited by 446
The Role of Reactive Oxygen Species in Arsenic Toxicity
Hu, Y., Li, J., Lou, B., Wu, R., Wang, G., Lu, C., Wang, H., Pi, J., & Xu, Y. (2020) · Biomolecules · doi:10.3390/biom10020240 · Cited by 413
Self-citationSingh, A. V., Ansari, M. H. D., Rosenkranz, D., Maharjan, R. S., Kriegel, F. L., Gandhi, K., Kanase, A., Singh, R., Laux, P., & Luch, A. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901862 · Cited by 310
Metadata
- Authors
- Zhuang, X., & Lu, C.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 6
- Issue
- 5
- Pages
- 430-440
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W2463304284
- Cited by
- 410
- References
- 29
- FWCI
- 28.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.